Published in Hepatology on August 01, 2009
Toward unraveling the complexity of simple epithelial keratins in human disease. J Clin Invest (2009) 2.34
"IF-pathies": a broad spectrum of intermediate filament-associated diseases. J Clin Invest (2009) 1.55
Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations. Gastroenterology (2010) 1.28
The genetics of complex cholestatic disorders. Gastroenterology (2013) 1.24
The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. Clin Liver Dis (2012) 0.97
Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C. Clin Gastroenterol Hepatol (2011) 0.90
Update on the genetics and genomics of PBC. J Autoimmun (2010) 0.88
Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol (2010) 0.86
Cytokeratin 8 is increased in hepatitis C virus cells and its ectopic expression induces apoptosis of SMMC7721 cells. World J Gastroenterol (2013) 0.82
Non-coding keratin variants associate with liver fibrosis progression in patients with hemochromatosis. PLoS One (2012) 0.82
Prevalence of genetic variants of keratins 8 and 18 in patients with drug-induced liver injury. BMC Med (2015) 0.82
Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients. J Gastroenterol (2013) 0.81
Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology (2016) 0.80
Genomic variants associated with primary biliary cirrhosis. Genome Med (2010) 0.78
Epiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganization. J Hepatol (2015) 0.77
Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinoma. BMC Gastroenterol (2012) 0.77
Human keratin 8 variants promote mouse acetaminophen hepatotoxicity coupled with c-jun amino-terminal kinase activation and protein adduct formation. Hepatology (2015) 0.76
Absence of keratin 8 or 18 promotes antimitochondrial autoantibody formation in aging male mice. FASEB J (2015) 0.76
Multiple roles for keratin intermediate filaments in the regulation of epithelial barrier function and apico-basal polarity. Tissue Barriers (2016) 0.75
Cytokeratins in gastroenterology. Systematic review. Prz Gastroenterol (2015) 0.75
Intermediate filament proteins of digestive organs: Physiology and pathophysiology. Am J Physiol Gastrointest Liver Physiol (2017) 0.75
Keratin 8 variants are associated with cryptogenic hepatitis. Virchows Arch (2012) 0.75
Primary biliary cirrhosis. N Engl J Med (2005) 7.59
Prognosis in primary biliary cirrhosis: model for decision making. Hepatology (1989) 3.83
New consensus nomenclature for mammalian keratins. J Cell Biol (2006) 3.27
'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol (2002) 3.00
Vimentin function in lymphocyte adhesion and transcellular migration. Nat Cell Biol (2006) 2.87
Intermediate filament proteins and their associated diseases. N Engl J Med (2004) 2.84
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol (1978) 2.63
Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev (1994) 2.51
Toward unraveling the complexity of simple epithelial keratins in human disease. J Clin Invest (2009) 2.34
Mid-gestational lethality in mice lacking keratin 8. Genes Dev (1993) 2.24
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology (2005) 2.15
Frequency of monosomy X in women with primary biliary cirrhosis. Lancet (2004) 2.13
The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum Mutat (2008) 1.97
Primary biliary cirrhosis. Lancet (2003) 1.90
Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol (1995) 1.71
A disease- and phosphorylation-related nonmechanical function for keratin 8. J Cell Biol (2006) 1.68
Keratin 8 mutations in patients with cryptogenic liver disease. N Engl J Med (2001) 1.55
Studying simple epithelial keratins in cells and tissues. Methods Cell Biol (2004) 1.43
Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment. J Cell Sci (2005) 1.39
Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies. Hepatology (2007) 1.37
Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am J Pathol (1997) 1.36
Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization. J Cell Sci (2007) 1.34
Keratin 20 helps maintain intermediate filament organization in intestinal epithelia. Mol Biol Cell (2003) 1.29
Keratins as susceptibility genes for end-stage liver disease. Gastroenterology (2005) 1.24
Keratin variants associate with progression of fibrosis during chronic hepatitis C infection. Hepatology (2006) 1.14
Diseases of epidermal keratins and their linker proteins. Exp Cell Res (2007) 1.13
Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kappaB activation. J Cell Sci (2004) 1.04
Analysis of keratin polypeptides 8 and 19 variants in inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 1.00
Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis (2003) 0.99
Genes and (auto)immunity in primary biliary cirrhosis. Genes Immun (2005) 0.96
A mutation of keratin 18 within the coil 1A consensus motif causes widespread keratin aggregation but cell type-restricted lethality in mice. Exp Cell Res (2007) 0.96
Developmental studies on expression of monoclonal antibody-defined cytokeratins by thymic epithelial cells from normal and autoimmune mice. J Histochem Cytochem (1988) 0.91
Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury. J Cell Sci (2003) 0.89
Genomics of liver fibrosis and cirrhosis. Semin Liver Dis (2007) 0.89
Denaturing temperature selection may underestimate keratin mutation detection by DHPLC. Hum Mutat (2006) 0.86
Genetics and genomics of primary biliary cirrhosis. Clin Liver Dis (2008) 0.86
Mortality attributable to cholestatic liver disease in the United States. Hepatology (2008) 0.85
Recent advances in the epidemiology of primary biliary cirrhosis. Clin Liver Dis (2008) 0.84
Altered T cell differentiation and Notch signaling induced by the ectopic expression of keratin K10 in the epithelial cells of the thymus. J Cell Biochem (2005) 0.81
Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis. J Gastroenterol Hepatol (2004) 0.79
Primary biliary cirrhosis. N Engl J Med (2005) 7.59
Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genet (2008) 6.42
Primary biliary cirrhosis. Hepatology (2009) 5.35
European population substructure: clustering of northern and southern populations. PLoS Genet (2006) 5.27
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet (2009) 4.84
Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum (2002) 3.30
New consensus nomenclature for mammalian keratins. J Cell Biol (2006) 3.27
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol (2002) 3.00
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J Hepatol (2010) 2.82
Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology (2011) 2.64
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
From Mallory to Mallory-Denk bodies: what, how and why? Exp Cell Res (2007) 2.61
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol (2003) 2.37
Toward unraveling the complexity of simple epithelial keratins in human disease. J Clin Invest (2009) 2.34
Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe (2008) 2.30
Panhematin provides a therapeutic benefit in experimental pancreatitis. Gut (2010) 2.23
Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol (2006) 2.18
ER stress controls iron metabolism through induction of hepcidin. Science (2009) 2.18
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology (2002) 2.18
Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology (2005) 2.17
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med (2006) 2.16
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology (2005) 2.15
Frequency of monosomy X in women with primary biliary cirrhosis. Lancet (2004) 2.13
Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology (2009) 2.11
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology (2007) 2.09
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology (2008) 2.05
Presence of fetal DNA in maternal plasma decades after pregnancy. Hum Genet (2002) 2.05
CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation. Hepatology (2013) 2.04
Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology (2011) 2.02
Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2. Chem Biol (2005) 2.00
Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med (2002) 2.00
"Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem Sci (2006) 1.97
Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology (2007) 1.93
Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut (2011) 1.91
Underrepresentation of underrepresented minorities in academic medicine: the need to enhance the pipeline and the pipe. Gastroenterology (2009) 1.91
IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology (2006) 1.91
Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol (2005) 1.89
Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. Nat Cell Biol (2003) 1.84
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83
Probiotics and immunity. J Gastroenterol (2009) 1.79
Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice. Hepatology (2013) 1.78
Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation. J Cell Biol (2011) 1.72
Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology (2002) 1.72
Drug-induced hepatotoxicity. Ann Ital Med Int (2003) 1.71
CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology (2015) 1.70
Identification of novel principles of keratin filament network turnover in living cells. Mol Biol Cell (2004) 1.68
A disease- and phosphorylation-related nonmechanical function for keratin 8. J Cell Biol (2006) 1.68
Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology (2004) 1.67
Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One (2008) 1.67
Telomerase gene mutations are associated with cirrhosis formation. Hepatology (2011) 1.67
Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology (2009) 1.65
Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest (2002) 1.65
Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol (2009) 1.62
The role of environmental factors in primary biliary cirrhosis. Trends Immunol (2009) 1.61
Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology (2009) 1.61
Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med (2008) 1.59
Respiratory syncytial virus--a comprehensive review. Clin Rev Allergy Immunol (2013) 1.57
Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun (2008) 1.57
Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am J Gastroenterol (2004) 1.57
The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev (2009) 1.57
Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev (2005) 1.57
The unfinished business of primary biliary cirrhosis. J Hepatol (2008) 1.56
Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding. Gut (2011) 1.56
Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (2009) 1.55
Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology (2006) 1.54
Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection. J Hepatol (2003) 1.53
Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J Immunol (2003) 1.53
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology (2006) 1.53
Huh-7: a human "hemochromatotic" cell line. Hepatology (2010) 1.51
Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Gastroenterology (2009) 1.51
The SAPHO syndrome. Semin Arthritis Rheum (2012) 1.50